BFC Planning’s Impact BioMedical IBO Stock Holding History
Bought
Maintained
Sold
Other funds holding IBO
BFC Planning's IBO Position: Q3 2026 in Review
BFC Planning held its Impact BioMedical (IBO) position steady in Q3 2026 at 17 shares worth $95. The position accounts for ﹤0.01% of the portfolio, ranked #3391.
BFC Planning first reported a position in IBO in Q3 2025 and has held it in 5 quarters since. The position peaked at $145 in Q3 2025. 16 funds tracked by Wall St. Rank hold IBO as of Q3 2026.
- BFC Planning held 17 shares of Impact BioMedical worth $95 as of Q3 2026.
- BFC Planning left its Impact BioMedical share count unchanged in Q3 2026.
- Impact BioMedical made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3391 holding.
- BFC Planning first reported a position in Impact BioMedical in Q3 2025 and has held it in 5 quarters since.
- BFC Planning's Impact BioMedical position peaked at $145 in Q3 2025.
- 16 funds tracked by Wall St. Rank held Impact BioMedical as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.